Diabetic Complications and Obstructive Sleep Apnea
Conditions
Keywords
Type 2 diabetes, diabetic complications, Obstructive Sleep Apnea
Brief summary
To follow up the progress of chronic complications in T2DM patients who had undergone anthropometric measurements, laboratory testing and standard overnight polysomnography monitor from 2013 to 2018.
Detailed description
Obstructive sleep apnea (OSA) is a common chronic sleep disorder and a frequent comorbidity in patients with type 2 diabetes. There has been increasing recognition that OSA is highly prevalent in persons with type 2 diabetes. This study is to explore the relationship between OSA and the progress of chronic diabetes-related complications in type 2 diabetes who had undergone anthropometric measurements, laboratory testing and standard overnight polysomnography monitor from 2013 to 2018 in the Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Interventions
OTHERregular treatment
The patients with or without OSA received regular hypoglycemic drugs.
Sponsors
The First Affiliated Hospital of Xiamen University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Type 2 diabetes * Age：18-80
Exclusion criteria
* Patients with non type 2 diabetes mellitus * Preparation for pregnancy * Lactation patients * Patients with uncontrolled thyroid disease * Patients with severe cardiovascular disease * Patients with severe hepatic and renal insufficiency * Patients with oral and maxillofacial malformations and upper respiratory tract malformations * Patients with pulmonary infection or COPD * Patients who are not willing to accept the questionnaire survey * Unable to sign informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the progress of diabetic complications | From January 1, 2013 to December 31, 2020 | Diabetic complications include diabetic microvascular complications, atherosclerotic cardiovascular disease(ASCVD), and Diabetic foot disease. Diabetic microvascular complications include diabetic nephropathy, diabetic retinopathy and diabetic neuropathy. Diabetic macrovascular complications refer to ASCVD, which is defined as coronary heart disease (CHD; acute and silent MI, and unstable angina), ischemic stroke, or peripheral artery disease (PAD). |
| the new onset and types of tumor in T2DM patients | From January 1, 2013 to December 31, 2020 | the new onset and types of tumor in T2DM patients |
Countries
China
Contacts
Primary ContactChangqin Liu, Dr.
Backup ContactXin Zheng
Outcome results
None listed